{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:05:03Z","timestamp":1793109903259,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.ejphar.2014.01.029","type":"journal-article","created":{"date-parts":[[2014,2,3]],"date-time":"2014-02-03T11:00:24Z","timestamp":1391425224000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Identification of a novel GPR81-selective agonist that suppresses lipolysis in mice without cutaneous flushing"],"prefix":"10.1016","volume":"727","author":[{"given":"Taku","family":"Sakurai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Stafford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Grosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumasa","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Parton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Sykes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Bousba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alka","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew","family":"Leveridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.01.029_bib1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.tips.2009.09.001","article-title":"GPR109A, GPR109B and GPR81, a family of hydroxy-carboxylic acid receptors","volume":"30","author":"Ahmed","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2014.01.029_bib2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cmet.2010.02.012","article-title":"An autocrine lactate loop mediates insulin-dependent inhibition of lipolysis through GPR81","volume":"11","author":"Ahmed","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejphar.2014.01.029_bib3","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1124\/mol.106.030833","article-title":"Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells","volume":"70","author":"Benyo","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.01.029_bib4","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1172\/JCI23626","article-title":"GPR109A (PUMA-G\/HM74A) mediates nicotinic acid-induced flushing","volume":"115","author":"Benyo","year":"2005","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2014.01.029_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/B978-0-12-385952-5.00005-1","article-title":"Biological and pharmacological roles of HCA receptors","volume":"62","author":"Blad","year":"2011","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.01.029_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/1367-8280(94)90024-8","article-title":"Effect of insulin and isoproterenol on lipid metabolism in porcine adipose tissue from different depots","volume":"108","author":"Budd","year":"1994","journal-title":"Comp. Biochem. Physiol. Pharmacol. Toxicol. Endocrinol."},{"key":"10.1016\/j.ejphar.2014.01.029_bib7","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.bbrc.2008.10.088","article-title":"Role of GPR81 in lactate-mediated reduction of adipose lipolysis","volume":"377","author":"Cai","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2014.01.029_bib8","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1073\/pnas.0601574103","article-title":"Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans","volume":"103","author":"Cheng","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2014.01.029_bib9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1021\/ml3000676","article-title":"Identification of hydroxybenzoic acids as selective lactate receptor(GPR81) agonists with antilipolytic effects","volume":"3","author":"Dvorak","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2014.01.029_bib10","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1194\/jlr.M700513-JLR200","article-title":"Elucidation of signaling and functional activities of an orphan GPCR, GPR81","volume":"49","author":"Ge","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2014.01.029_bib11","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1172\/JCI42273","article-title":"Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice","volume":"120","author":"Hanson","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2014.01.029_bib12","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4065\/mcp.2009.0535","article-title":"A \u201chot\u201d topic in dyslipidemia management\u2014\u201chow to beat a flush\u201d: optimizing niacin tolerability to promote long-term treatment adherence and coronary disease prevention","volume":"85","author":"Jacobson","year":"2010","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ejphar.2014.01.029_bib13","doi-asserted-by":"crossref","first-page":"19649","DOI":"10.1074\/jbc.M200743200","article-title":"T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities","volume":"277","author":"Lee","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2014.01.029_bib14","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1074\/jbc.M806409200","article-title":"Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81","volume":"284","author":"Liu","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2014.01.029_bib15","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0022-3565(25)21176-4","volume":"279","author":"Masuda","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2014.01.029_bib16","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.tips.2006.05.008","article-title":"The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target","volume":"27","author":"Offermanns","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2014.01.029_bib17","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1172\/JCI27160","article-title":"Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid","volume":"115","author":"Pike","year":"2005","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2014.01.029_bib18","first-page":"271","article-title":"Identification of a nicotinic acid receptor: is this the molecular target for the oldest lipid-lowering drug?","volume":"5","author":"Pike","year":"2004","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.ejphar.2014.01.029_bib19","doi-asserted-by":"crossref","first-page":"18028","DOI":"10.1074\/jbc.M701866200","article-title":"Nicotinic acid receptor agonists differentially activate downstream effectors","volume":"282","author":"Richman","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2014.01.029_bib20","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/nrendo.2011.72","article-title":"Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment","volume":"7","author":"Smith","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ejphar.2014.01.029_bib21","doi-asserted-by":"crossref","first-page":"9869","DOI":"10.1074\/jbc.M210695200","article-title":"Molecular identification of high and low affinity receptors for nicotinic acid","volume":"278","author":"Wise","year":"2003","journal-title":"J. Biol. Chem."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991400048X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991400048X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T15:15:34Z","timestamp":1746112534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991400048X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":21,"alternative-id":["S001429991400048X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.01.029","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of a novel GPR81-selective agonist that suppresses lipolysis in mice without cutaneous flushing","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}